Cardiac Involvement in Eosinophilic Granulomatosis With Polyangiitis: A Retrospective Study in the Chinese Population

被引:11
|
作者
Chen, Yingying [1 ]
Guo, Xiaoxiao [2 ]
Zhou, Jiaxin [1 ]
Li, Jing [1 ]
Wu, Qingjun [1 ]
Yang, Hongxian [3 ]
Zhang, Shangzhu [1 ]
Fei, Yunyun [1 ]
Zhang, Wen [1 ]
Zhao, Yan [1 ]
Zhang, Fengchun [1 ]
Zeng, Xiaofeng [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Natl Clin Res Ctr Dermatol & Immunol Dis NCRCDID, Dept Rheumatol,Key Lab,Minist Hlth, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Dept Cardiol, Peking Union Med Coll Hosp, Beijing, Peoples R China
[3] Capital Inst Pediat, Childrens Hosp, Dept Nephrol, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
eosinophilic granulomatosis with polyangitis; cardiac involvement; clinical characteristics; outcome; Chinese population; CHURG-STRAUSS-SYNDROME; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; TERM-FOLLOW-UP; POLYARTERITIS-NODOSA; ALLERGIC GRANULOMATOSIS; VASCULITIS; MEPOLIZUMAB; CLASSIFICATION; PREVALENCE; IMPACT;
D O I
10.3389/fmed.2020.583944
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Cardiac involvement in eosinophilic granulomatosis with polyangiitis (EGPA) is associated with a poor prognosis and high mortality; however, few studies about cardiac involvement in EGPA in the Chinese population are available. We conducted this study to determine the clinical characteristics and overall outcomes of Chinese EGPA patients with cardiac involvement. Materials and Methods: We retrospectively collected the clinical data of 83 patients diagnosed with EGPA and analyzed the differences between the patients with and without cardiac involvement. Results: The prevalence of cardiac involvement in EGPA in this cohort was 27.7%. Compared with those without cardiac involvement, EGPA patients with cardiac involvement tended to have a younger age at onset (mean +/- SD: 38.4 +/- 10.5 vs. 42.1 +/- 15.9 years, respectively, p = 0.039), higher eosinophil count (median [IQR]: 5810 [4020-11090] vs. 2880 [1530-6570] n/mu L, respectively, p = 0.004), higher disease activity assessed using the Birmingham vasculitis activity score (BVAS) (median [IQR]: 20 [16-28] vs. 15 [12-18], respectively, p = 0.001), and poorer prognosis (Five Factor Score [FFS] >= 1: 100% vs. 38.3%, respectively, p = 0.001). In the cardiac involvement group, 43.5% of patients were asymptomatic, but cardiac abnormalities could be detected by cardiac examinations. With appropriate treatment, the overall outcomes of EGPA patients with cardiac involvement in our cohort were good, with only 3 (13.0%) patients dying in the acute phase and no patients dying during follow-up. Conclusions: Cardiac involvement in EGPA was associated with a younger age at onset, higher eosinophil count, higher disease activity, and a poorer prognosis. Comprehensive cardiac examinations and appropriate treatment are essential to improve the prognosis of those with cardiac involvement.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Clinical features of central nervous system involvement in patients with eosinophilic granulomatosis with polyangiitis: a retrospective cohort study in China
    Suying Liu
    Ling Guo
    Xiaoyuan Fan
    Zhaocui Zhang
    Jiaxin Zhou
    Xinping Tian
    Mengtao Li
    Xiaofeng Zeng
    Li Wang
    Fengchun Zhang
    Orphanet Journal of Rare Diseases, 16
  • [42] Clinical features of central nervous system involvement in patients with eosinophilic granulomatosis with polyangiitis: a retrospective cohort study in China
    Liu, Suying
    Guo, Ling
    Fan, Xiaoyuan
    Zhang, Zhaocui
    Zhou, Jiaxin
    Tian, Xinping
    Li, Mengtao
    Zeng, Xiaofeng
    Wang, Li
    Zhang, Fengchun
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [43] Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven cases
    Durel, Cecile-Audrey
    Sinico, Renato A.
    Teixeira, Vitor
    Jayne, David
    Belenfant, Xavier
    Marchand-Adam, Sylvain
    Pugnet, Gregory
    Gaultier, Jacques
    Le Gallou, Thomas
    Titeca-Beauport, Dimitri
    Agard, Christian
    Barbet, Christelle
    Bardy, Antoine
    Blockmans, Daniel
    Boffa, Jean-Jacques
    Bouet, Julien
    Cottin, Vincent
    Crabol, Yoann
    Deligny, Christophe
    Essig, Marie
    Godmer, Pascal
    Guilpain, Philippe
    Hirschi-Santelmo, Sandrine
    Rafat, Cedric
    Puechal, Xavier
    Taille, Camille
    Karras, Alexandre
    RHEUMATOLOGY, 2021, 60 (01) : 359 - 365
  • [44] Eosinophilic Granulomatosis with Polyangiitis
    Shukla, Ratnakar
    Kandikatla, Ashwini
    Nadkarni, NitinJ
    Patil, Anant
    INTERNATIONAL JOURNAL OF APPLIED AND BASIC MEDICAL RESEARCH, 2022, 12 (02) : 148 - 150
  • [45] Eosinophilic granulomatosis with polyangiitis
    Boudreaux, B. L.
    Perez, A.
    Bajracharya, S.
    Barry, S.
    Mohandas, R.
    Aguilar, E. A.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 365 : S263 - S264
  • [46] Eosinophilic granulomatosis with polyangiitis
    Villa-Forte, Alexandra
    POSTGRADUATE MEDICINE, 2023, 135 : 52 - 60
  • [47] Eosinophilic Granulomatosis with Polyangiitis
    Yong, Geng-Yi
    Lim, Amelia L. -S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (04): : 374 - 374
  • [48] Eosinophilic Granulomatosis With Polyangiitis
    Korman, Abraham M.
    Chung, Catherine G.
    JAMA DERMATOLOGY, 2021, 157 (06) : 722 - 722
  • [49] Rituximab For Refractory Granulomatosis With Polyangiitis And For Eosinophilic Granulomatosis With Polyangiitis
    Kawano-Dourado, L.
    De Oliveira Filho, J. B.
    Lima, R. M.
    Tavares, M. S.
    Barbas, C. S. V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [50] VENTRICULAR FIBRILLATION DUE TO CARDIAC EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
    Nies, Sarah
    Collins, Steven
    Henery, Daniel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 4344 - 4344